|
Sarkar, S; Julicher, K P; Burger, M S et al. (2000) Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers. Cancer Res 60:3862-71
|
|
Cuthill, S; Agarwal, P; Sarkar, S et al. (1999) Dominant genetic alterations in immortalization: role for 20q gain. Genes Chromosomes Cancer 26:304-11
|
|
Vieten, L; Belair, C D; Savelieva, L et al. (1998) Minimal deletion of 3p13-->14.2 associated with immortalization of human uroepithelial cells. Genes Chromosomes Cancer 21:39-48
|
|
Yeager, T R; Reznikoff, C A (1998) Methotrexate resistance in human uroepithelial cells with p53 alterations. J Urol 159:581-5
|
|
Belair, C D; Yeager, T R; Lopez, P M et al. (1997) Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci U S A 94:13677-82
|
|
Reznikoff, C A; Belair, C D; Yeager, T R et al. (1996) A molecular genetic model of human bladder cancer pathogenesis. Semin Oncol 23:571-84
|
|
Puthenveettil, J A; Frederickson, S M; Reznikoff, C A (1996) Apoptosis in human papillomavirus16 E7-, but not E6-immortalized human uroepithelial cells. Oncogene 13:1123-31
|
|
Reznikoff, C A; Yeager, T R; Belair, C D et al. (1996) Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res 56:2886-90
|
